| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Laboratory of Biomedical Genetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Hongo, Bunkyo-ku, Tokyo 113-0033 [K. T., A. M., N. S., M. M. T.], and Banyu Tsukuba Research Institute (Merck), Tsukuba, Ibaraki 300-2611 [H. M., M. O.], Japan
The SMAD4 (DPC4) gene was initially isolated as a candidate tumor suppressor from the convergent site of homozygous deletions on 18q in a panel of pancreatic carcinoma cell lines. It encodes a common cytoplasmic signaling molecule shared by the transforming growth factor-
, activin, and bone morphogenic pathways. We recently inactivated its mouse homologue Smad4 and demonstrated its role in the malignant progression of benign adenomas to invasive adenocarcinomas by analyzing mice with Apc and Smad4 compound mutations. Although simple Smad4 homozygotes were embryonically lethal, the heterozygotes were fertile and appeared normal up to the age of 1 year. Upon further investigation, however, they have developed inflammatory polyps in the glandular stomach and duodenum. By PCR genotyping and immunohistochemical staining, the wild-type Smad4 allele has been lost in the polyp epithelial cells, i.e., loss of heterozygosity. On the other hand, we have not found any mutations in such genes as K-Ras, H-Ras, N-Ras, p53, or PTEN. Histologically, the polyps are similar to human juvenile polyps showing moderate stromal cell proliferation and infiltrations by eosinophils and plasma cells. In addition, foci of adenocarcinoma with signet ring cells are also found. These results are consistent with a recent report that germ-line SMAD4 mutations are found in a subset of familial juvenile polyposis.
This article has been cited by other articles:
![]() |
D. Pan, T. Schomber, C. P. Kalberer, L. M. Terracciano, K. Hafen, W. Krenger, H. Hao-Shen, C. Deng, and R. C. Skoda Normal erythropoiesis but severe polyposis and bleeding anemia in Smad4-deficient mice Blood, October 15, 2007; 110(8): 3049 - 3055. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Karlsson, U. Blank, J. L. Moody, M. Ehinger, S. Singbrant, C.-X. Deng, and S. Karlsson Smad4 is critical for self-renewal of hematopoietic stem cells J. Exp. Med., March 19, 2007; 204(3): 467 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-H. Wang, S.-H. Kim, J. H. Lee, Y.-L. Choi, Y. C. Kim, T. S. Park, Y.-C. Hong, C.-F. Wu, and Y. K. Shin Inactivation of SMAD4 Tumor Suppressor Gene During Gastric Carcinoma Progression Clin. Cancer Res., January 1, 2007; 13(1): 102 - 110. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bardeesy, K.-h. Cheng, J. H. Berger, G. C. Chu, J. Pahler, P. Olson, A. F. Hezel, J. Horner, G. Y. Lauwers, D. Hanahan, et al. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes & Dev., November 15, 2006; 20(22): 3130 - 3146. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Munoz, M. Upton, A. Rojas, M. K. Washington, L. Lin, A. Chytil, E. G. Sozmen, B. B. Madison, A. Pozzi, R. T. Moon, et al. Transforming Growth Factor {beta} Receptor Type II Inactivation Induces the Malignant Transformation of Intestinal Neoplasms Initiated by Apc Mutation. Cancer Res., October 15, 2006; 66(20): 9837 - 9844. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ge, V. Rajeev, P. Ray, E. Lattime, S. Rittling, S. Medicherla, A. Protter, A. Murphy, J. Chakravarty, S. Dugar, et al. Inhibition of Growth and Metastasis of Mouse Mammary Carcinoma by Selective Inhibitor of Transforming Growth Factor-{beta} Type I Receptor Kinase In vivo. Clin. Cancer Res., July 15, 2006; 12(14): 4315 - 4330. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Oliveira, R. Seruca, and F. Carneiro Genetics, Pathology, and Clinics of Familial Gastric Cancer International Journal of Surgical Pathology, January 1, 2006; 14(1): 21 - 33. [Abstract] [PDF] |
||||
![]() |
M. Ohgushi, S. Kuroki, H. Fukamachi, L. A. O'Reilly, K. Kuida, A. Strasser, and S. Yonehara Transforming Growth Factor {beta}-Dependent Sequential Activation of Smad, Bim, and Caspase-9 Mediates Physiological Apoptosis in Gastric Epithelial Cells Mol. Cell. Biol., November 15, 2005; 25(22): 10017 - 10028. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jazag, F. Kanai, H. Ijichi, K. Tateishi, T. Ikenoue, Y. Tanaka, M. Ohta, J. Imamura, B. Guleng, Y. Asaoka, et al. Single small-interfering RNA expression vector for silencing multiple transforming growth factor-{beta} pathway components Nucleic Acids Res., August 19, 2005; 33(15): e131 - e131. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Z. Rizvi and M. H. Wong Epithelial Stem Cells and Their Niche: There's No Place Like Home Stem Cells, February 1, 2005; 23(2): 150 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Chu, N. R. Dunn, D. C. Anderson, L. Oxburgh, and E. J. Robertson Differential requirements for Smad4 in TGF{beta}-dependent patterning of the early mouse embryo Development, August 1, 2004; 131(15): 3501 - 3512. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-P. G. Haramis, H. Begthel, M. van den Born, J. van Es, S. Jonkheer, G. J. A. Offerhaus, and H. Clevers De Novo Crypt Formation and Juvenile Polyposis on BMP Inhibition in Mouse Intestine Science, March 12, 2004; 303(5664): 1684 - 1686. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-F. Chu, R. S. Esworthy, P. G. Chu, J. A. Longmate, M. M. Huycke, S. Wilczynski, and J. H. Doroshow Bacteria-Induced Intestinal Cancer in Mice with Disrupted Gpx1 and Gpx2 Genes Cancer Res., February 1, 2004; 64(3): 962 - 968. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Flanders and J. K. Burmester Medical Applications of Transforming Growth Factor-{beta} Clin. Med. Res., January 1, 2003; 1(1): 13 - 20. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Biankin, A. L. Morey, C.-S. Lee, J. G. Kench, S. A. Biankin, H. C. Hook, D. R. Head, T. B. Hugh, R. L. Sutherland, and S. M. Henshall DPC4/Smad4 Expression and Outcome in Pancreatic Ductal Adenocarcinoma J. Clin. Oncol., December 1, 2002; 20(23): 4531 - 4542. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.G. Sayed, A.F. Ahmed, J.R. Ringold, M.E. Anderson, J.L. Bair, F.A. Mitros, H.T. Lynch, S.T. Tinley, G.M. Petersen, F.M. Giardiello, et al. Germline SMAD4 or BMPR1A Mutations and Phenotype of Juvenile Polyposis Ann. Surg. Oncol., November 1, 2002; 9(9): 901 - 906. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Peng, J. B. Fleming, T. Breslin, A. M. Grau, S. Fojioka, J. L. Abbruzzese, D. B. Evans, D. Ayers, K. Wathen, T. Wu, et al. Suppression of Tumorigenesis and Induction of p15ink4b by Smad4/DPC4 in Human Pancreatic Cancer Cells Clin. Cancer Res., November 1, 2002; 8(11): 3628 - 3638. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hamamoto, H. Beppu, H. Okada, M. Kawabata, T. Kitamura, K. Miyazono, and M. Kato Compound Disruption of Smad2 Accelerates Malignant Progression of Intestinal Tumors in Apc Knockout Mice Cancer Res., October 15, 2002; 62(20): 5955 - 5961. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Miyoshi, M. Nakau, T.-o Ishikawa, M. F. Seldin, M. Oshima, and M. M. Taketo Gastrointestinal Hamartomatous Polyposis in Lkb1 Heterozygous Knockout Mice Cancer Res., April 1, 2002; 62(8): 2261 - 2266. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Woodford-Richens, A. J. Rowan, R. Poulsom, S. Bevan, R. Salovaara, L. A. Aaltonen, R. S. Houlston, N. A. Wright, and I. P. M. Tomlinson Comprehensive Analysis of SMAD4 Mutations and Protein Expression in Juvenile Polyposis : Evidence for a Distinct Genetic Pathway and Polyp Morphology in SMAD4 Mutation Carriers Am. J. Pathol., October 1, 2001; 159(4): 1293 - 1300. [Abstract] [Full Text] |
||||
![]() |
C. Xiangming, S. Natsugoe, S. Takao, S. Hokita, S. Ishigami, G. Tanabe, M. Baba, K. Kuroshima, and T. Aikou Preserved Smad4 Expression in the Transforming Growth Factor {beta} Signaling Pathway Is a Favorable Prognostic Factor in Patients with Advanced Gastric Cancer Clin. Cancer Res., February 1, 2001; 7(2): 277 - 282. [Abstract] [Full Text] |
||||
![]() |
M. P. de Caestecker, E. Piek, and A. B. Roberts Role of Transforming Growth Factor-{beta} Signaling in Cancer J Natl Cancer Inst, September 6, 2000; 92(17): 1388 - 1402. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Saha, P. K. Datta, and R. D. Beauchamp Oncogenic Ras Represses Transforming Growth Factor-beta /Smad Signaling by Degrading Tumor Suppressor Smad4 J. Biol. Chem., July 27, 2001; 276(31): 29531 - 29537. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |